Two Indian-origin millionaire brothers were today caught in a controversy for allegedly exploiting a loophole in Britain's state-run National Health Service's pricing controls to overcharge for the sale of generic drugs, according to a media report.
Two Indian-origin millionaire brothers were today caught in a controversy for allegedly exploiting a loophole in Britain's state-run National Health Service's pricing controls to overcharge for the sale of generic drugs, according to a media report.